• Multiple factors contribute to changes in healthcare financing.
• Market Street’s different platforms provide capital markets and advisory guidance.
• With more than $3 billion in completed transactions, Market Street provides advisory and capital markets services for healthcare financings.

Healthcare and diagnostics operators are facing consolidation pressure, reimbursement uncertainty and more selective sponsors all at once. In that environment, how a capital raise is structured can matter as much as the business behind it. Market Street Capital is a boutique capital markets and financial advisory firm that works with established middle-market businesses navigating pivotal moments in their development, focusing on companies with enterprise values from $10 million to $1 billion.

Reimbursement is the first reason healthcare financing looks different right now. Clinical laboratories offer a clear example. The Consolidated Appropriations Act of 2026, signed Feb. 3, delayed Medicare lab fee schedule cuts through 2026. According to the Centers for Medicare & Medicaid Services (“CMS”), payments for affected tests may decline beginning in 2027, subject to a statutory phase-in cap of 15% per test per year through 2029; CMS published preliminary 2027 rates in September 2026, with final rates pending. The American Clinical Laboratory Association has said roughly 800 tests are exposed.

Uncertainty like this complicates underwriting. Healthcare-focused lenders dig deeper into revenue sources, separating Medicare, Medicaid, commercial insurance and private pay. They also weigh reimbursement rate changes and management agreement structures when assessing collateral and downside scenarios.

Fragmented subsectors are consolidating as operators seek scale. In diagnostics, national chains bring outcomes data at scale to payer negotiations. Regulatory and administrative burdens also weigh more heavily on small labs, which may favor larger operators. The pattern extends beyond labs. Physician medical groups accounted for 46% of first-quarter health services deal volume, up from 37% a year earlier, and private equity drove most deal flow through platform add-ons.

Sponsors remain active but are more discerning. Healthcare private equity posted record disclosed deal value above $191 billion in 2025. PwC nonetheless characterizes the first half of 2026 as a selective, conviction-led market, with buyers favoring reimbursement visibility, margin durability and execution readiness. Deal volume softened even as value held up. Contracted payer relationships and recurring revenue command the strongest pricing, while material investigations or audit findings may affect valuation or transaction execution.

Those conditions may affect healthcare financing. Lenders may consider reimbursement diversification and documented compliance controls. Healthcare accounted for roughly 22% of U.S. direct lending issuance through March 2026, the largest share of any sector, but RSM cautions that the easy phase of private credit in healthcare has passed. Lenders expect new deals to carry lower leverage and stronger protections. Depending on cash flow, collateral and investor requirements, a financing may combine senior debt with mezzanine financing or minority equity.

Healthcare diligence can involve sector-specific review. Alongside standard financial review, buyers and lenders scrutinize payer contracts, analyze payer mix and denial rates, and map financial relationships against the Stark Law and Anti-Kickback Statute. That review matters because potential compliance risks may carry over with the business in an acquisition.

This is where Market Street Capital fits. Its Debt Capital Markets & Specialty Lending practice works with middle-market clients seeking financing from banks, private credit funds, insurance companies and specialty finance providers. It advises on senior debt, unitranche and mezzanine financing, and asset-based lending tied to receivables. Its Private Equity Raises practice advises on growth funding and recapitalizations involving private equity, family offices and institutional capital. Securities placement services, where applicable, are provided through Pickwick Capital Partners, LLC, Member FINRA/SIPC. No capital raise or transaction outcome is assured.

The firm’s broader investment banking platform addresses consolidation directly. Its Mergers & Acquisitions team handles sell-side and buy-side advisory, including work for private equity sponsors building platforms. Market Street’s valuation capabilities support transaction planning and capital events.

The firm also maintains a syndication network of more than 8,000 investors, family offices, venture capital firms and banks and highlights its access to private equity sponsors and strategic acquirers. Such relationships may assist in identifying counterparties with relevant mandates. With more than $3 billion in completed transactions, Market Street offers capital markets and advisory services relevant to healthcare financings.

Healthcare capital raises demand more layered diligence and more selective sponsor targeting than most middle-market sectors. Reimbursement exposure, compliance history and payer concentration all shape what lenders will extend and what sponsors will pay. Market Street Capital offers advisory services addressing capital markets and sector-specific financing considerations.

For more information about the company, visit www.MarketStreetCP.com.

NOTE TO INVESTORS: The latest news and updates relating to Market Street are available in the company’s newsroom at https://ibn.fm/MarketSt

Disclosures:

This article is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. Any such offer may be made only pursuant to definitive offering materials and applicable transaction documents.

Nothing in this article is tax, legal or accounting advice. Readers should consult their own advisers.

Market data and third-party information are from sources believed to be reliable but have not been independently verified. No representation is made as to accuracy or completeness. Statements about financing structures and transaction outcomes are general in nature; no financing or transaction outcome can be assured. Any investment in securities is illiquid and speculative and is subject to a risk of loss, including a risk of the total loss of principal. Market Street Capital and its associated persons may have conflicts of interest, including transaction-based compensation, in connection with the services described.

Broker-dealer services are provided by Pickwick Capital Partners, LLC, Member FINRA/SIPC.

Disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

• Gold had an extraordinary run, trading above $5,000 an ounce earlier this year and projected to remain above $5,000 at year end.
• Lahontan Gold announced a definitive agreement to acquire Emergent Metals Corp., a transaction that would consolidate Lahontan’s ownership of the Santa Fe West property to 100%.
• “The acquisition of Emergent Metals represents another important step in Lahontan’s disciplined growth strategy,” says company founder.

Gold is trading near historic highs, and investors are looking for developers who can turn that price strength into real ounces in the ground. Dual-listed on the TSX Venture Exchange and OTCQB, Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) (FSE:Y2F) is one of those developers, advancing a package of gold and silver projects in Nevada’s Walker Lane trend. The company recently took a significant step toward that goal, consolidating ownership of a key project and eliminating royalty obligations along the way.

The precious metal has had an extraordinary run. Spot prices broke above $5,000 an ounce for the first time in January 2026, then briefly topped $5,500 before pulling back. By mid-September, gold was trading near $4,300 an ounce.

Central bank buying has been the biggest driver of that rally. The World Gold Council has tracked record-setting purchases from central banks, alongside strong demand for gold-backed ETFs and safe-haven flows tied to geopolitical tension. Goldman Sachs has raised its 2026 year-end price target to $5,400 an ounce, while Morgan Stanley has pointed to $5,200.

That price backdrop changes the math for gold developers. Projects that were once marginal at lower prices can become economic, and companies with defined resources and a path to production tend to draw more investor attention. Nevada’s Walker Lane, a mineral-rich trend that has produced gold for more than a century, is one of the regions benefiting most from that renewed interest.

Lahontan Gold Corp. sits squarely inside that trend. In September, the company announced a definitive agreement to acquire Emergent Metals Corp., a transaction that would consolidate Lahontan’s ownership of the Santa Fe West property to 100%, further strengthening its position at the Santa Fe Mine project in Nevada.

The transaction gives Lahontan full ownership of its West Santa Fe project. It also eliminates a 1% net smelter return royalty on that property, along with a matching royalty on 27 adjacent York claims. The deal adds the New York Canyon project, which sits directly along the southern boundary of the Santa Fe Mine, bringing Lahontan’s total Walker Lane land package to more than 93 square kilometers.

Lahontan is also picking up additional assets through the deal, including a promissory note and equity stake tied to Emergent’s prior sale of its Golden Arrow property, along with a portfolio of gold royalties in Quebec and a package of leased mining claims in Nevada. An independent fairness opinion from Evans & Evans Inc. found the consideration fair to Emergent shareholders, and Emergent’s board has unanimously recommended the deal.

“The acquisition of Emergent Metals represents another important step in Lahontan’s disciplined growth strategy,” said Lahontan Gold founder, chair, CEO and president Kimberly Ann. “This transaction consolidates our ownership of West Santa Fe, eliminates royalties at both West Santa Fe and the York claims at Santa Fe, adds the strategically important New York Canyon project to our regional-scale Walker Lane land package, and provides Lahontan with additional royalties, claims and other assets.”

The company’s growth strategy centers on the Santa Fe Mine, a past-producing operation that yielded 359,202 ounces of gold and 702,067 ounces of silver between 1988 and 1995, according to Nevada Bureau of Mines records cited in the release. The project currently carries a NI 43-101 compliant indicated resource of 1,195,000 gold-equivalent ounces, plus an inferred resource of 1,190,000 gold-equivalent ounces. Santa Fe sits alongside three other projects in Lahontan’s Nevada portfolio: West Santa Fe, Moho and Redlich.

Lahontan’s stated objectives for 2026 include completing an updated preliminary economic assessment for Santa Fe, advancing mine permitting with construction targeted for 2027 and drilling toward a maiden resource estimate at West Santa Fe by year-end. Combined with the elimination of royalty payments and a larger, consolidated Nevada land position, the Emergent transaction gives Lahontan a stronger platform to advance that plan, right as gold prices continue to reward developers who can move toward near-term production.

For more information, visit the company’s website at www.LahontanGoldCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to LGCXF are available in the company’s newsroom at ibn.fm/LGCXF

• Silynxcom recently received two purchase orders for Silynxcom’s CLARUS In-Ear Headset products totalling approximately $400,000, are from a leading global defense company.
• The primary importance of the orders, designated for a European army, is that they reflect continued demand from European defense customers.
• The orders show Silynxcom’s strong relationship with a leading global defense company and a growing reputation among European forces.

Silynxcom (NYSE American: SYNX), a manufacturer and developer of ruggedized tactical communication and hearing-protection devices, as well as other gear and accessories, recently announced that it received two consecutive purchase orders from a leading global defense company, totalling around $400,000 (https://ibn.fm/mfabV).

These orders were for Silynxcom’s CLARUS In-Ear Headset system family of products, and the systems are designated for a European army. The CLARUS system is a fully modular tactical communication system that offers hearing protection, situational awareness, an in-ear microphone, and several advanced features like drone detection.

Speaking about these orders, Nir Klein, the CEO of Silynxcom, said that “We believe these two consecutive orders reflect both the strength of our relationship with a leading global defense company and the growing recognition among European defense forces of Silynxcom’s ability to deliver reliable, mission-critical communication solutions that enhance operational effectiveness and soldier safety.”

He also added that “We are proud that our systems continue to be deployed by European armed forces, and we view these orders as a further step in our expanding presence across European markets. Our in-ear platform is increasingly being evaluated by military and defense organizations globally, as customers seek combat-proven communication solutions.”

About Silynxcom Ltd. (NYSE American: SYNX)

Silynxcom is a developer and manufacturer of ruggedized tactical communication and hearing-protection systems designed for use in a variety of demanding environments. This includes the military, law enforcement, riot control, shooting sport, and industrial settings. Silynxcom has its roots in sound science and acoustics, and designs products that combine hearing protection, clear communication, and environmental awareness in one system.

For more information, visit Silynx’s website at https://silynxcom.com.

NOTE TO INVESTORS: The latest news and updates relating to SYNX are available in the company’s newsroom at https://ibn.fm/SYNX

PAID ADVERTISEMENT. This article is a paid advertisement for BOXABL Inc. (Nasdaq: BXBL), distributed by NetworkNewsWire (“NNW”), a division of InvestorBrandNetwork (“IBN”). IBN has been compensated for advertising and digital media services related to BOXABL Inc. Readers should review the full disclaimer at the foot of this article before making any investment decision.

Goldsmith spent nearly 21 years at EY, including serving as an audit partner from 2018 to 2026, covering oversight of more than 20 public and private company audits, SEC reporting, and financial controls.

He will also join BOXABL’s Nominating and Corporate Governance Committee, while outgoing Audit Committee Chair Morris A. Davis remains a member of the Audit Committee.

The appointment follows recent finance leadership additions Larry King as CFO and Heather Clayton as chief accounting officer.

BOXABL (NASDAQ: BXBL), an innovative technology company transforming the housing market with its modular building systems, has appointed former EY audit partner Timothy Goldsmith, CPA, as a director and chair of its Audit Committee, adding public-company accounting and regulatory experience as the factory-built housing company expands its financial and governance structure (https://ibn.fm/HKa2M).

The appointment took effect September 24, 2026. Goldsmith will also serve on the Nominating and Corporate Governance Committee. Morris A. Davis, who previously chaired the Audit Committee, will remain on it as a member.

Goldsmith’s appointment is the latest in a series of finance and governance additions at BOXABL, which began trading on NASDAQ under the ticker BXBL in July after completing its business combination with FG Merger II Corp. The company recently named Larry King chief financial officer and Heather Clayton chief accounting officer.

Goldsmith spent nearly 21 years at EY, most recently as an audit partner between 2018 and 2026. During that period, he oversaw more than 20 complex audits of public and private companies and led a team of more than 30 audit executives. His work included companies with annual revenue ranging from $200 million to more than $3 billion.

His technical experience spans U.S. generally accepted accounting principles, International Financial Reporting Standards, SEC and Public Company Accounting Oversight Board requirements, and Sarbanes-Oxley compliance. He also worked on merger and acquisition accounting, business combinations and consolidated financial reporting.

Earlier in his career, Goldsmith served in EY’s Assurance and Advisory practice and worked as a U.S. SEC capital markets and professional practice senior in Hong Kong. In that role, he advised on cross-border transactions and initial public offerings involving U.S. operations.

The background is relevant as BOXABL strengthens the internal processes expected of a listed company. Audit committees oversee financial reporting and the relationship with external auditors, while governance committees typically address board composition and related policies. Goldsmith’s experience advising audit committees and boards gives him direct familiarity with those responsibilities.

BOXABL founder and co-CEO Paolo Tiramani said the appointment reflects the company’s focus on financial discipline as it scales. “Tim’s two decades at EY, including years spent advising audit committees and boards at public companies across manufacturing, gaming and hospitality, make him exactly the kind of governance partner we need as we scale,” said Tiramani. “Combined with the strength Larry and Heather will bring to our finance team, this appointment reflects how seriously we’re taking the discipline and rigor that come with being a public company.”

Goldsmith said he intends to work with management and the board to build the governance foundation required at this stage. “BOXABL is tackling one of the country’s most pressing challenges, the shortage of affordable housing, with a genuinely innovative manufacturing model. Having spent nearly 21 years in public accounting, I understand how important strong financial controls and governance are for a company at this stage of growth, especially one that has recently gone public. I’m looking forward to working with the board and management team to help build that foundation as BOXABL scales,” said Goldsmith.

The company’s operational ambitions center on factory-built housing and its flagship Casita, a 361-square-foot studio unit with a kitchen, bathroom and utilities. BOXABL says the unit folds for transport and unfolds at the final site in under an hour, using a patented folding and shipping approach that it positions as a distinction from conventional modular construction.

The company is also developing stackable and connectable modules intended to form larger homes and multifamily structures. Its manufacturing model is designed to shift a substantial part of construction activity into a factory environment, with the aim of improving consistency and reducing some transportation and on-site installation costs.

For more information, visit the company’s website at www.Boxabl.com.

NOTE TO INVESTORS: The latest news and updates relating to BXBL are available in the company’s newsroom at https://ibn.fm/BXBL

Cautionary Note Regarding the Business Combination and Capital Structure. BOXABL Inc. became a publicly traded company through a business combination with FG Merger II Corp., a special purpose acquisition company, completed in July 2026, with the shares beginning trading on the Nasdaq Stock Market under the symbol BXBL on July 20, 2026. Companies that become public through special purpose acquisition transactions may be subject to risks including share price volatility, dilution, limited operating history as a public company, and redemption-related capital reductions. In July 2026 the Company filed a universal mixed shelf registration statement that would permit it to offer up to $500,000,000 of securities over time; any such issuance would be dilutive to existing holders. References to capital raised since inception and to the number of investors are as disclosed by the Company. Readers should review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov, including its periodic reports, in full.

Cautionary Note Regarding Forward-Looking Statements. This publication contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including projections of market opportunity and market share, estimates of customer adoption, projections of development and commercialization costs and timelines, expectations regarding the Company’s ability to execute its business model, the deployment of the Casita, the development and potential production of the Baby Box and of stackable and connectable modules, the pursuit of additional state regulatory approvals, expectations concerning relationships with customers, developers, strategic partners, suppliers, governments and regulatory bodies, the Company’s public-company reporting, finance infrastructure and board governance, and the potential for future projects. Such statements are generally identified by words such as “plan”, “project”, “will”, “estimate”, “intend”, “expect”, “believe”, “target”, “continue”, “could”, “may”, “might”, “possible”, “potential” or “predict”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause actual circumstances, events, or results to differ materially, including manufacturing, supply chain, permitting, regulatory, financing, dilution, listing, competitive and market risks, and other risks identified in the Company’s filings with the Securities and Exchange Commission. Do not place undue reliance on such statements. The forward-looking statements in this publication are made as of the date above and IBN undertakes no obligation to update them.

Full Disclaimer. NetworkNewsWire (“NNW”) is a division of InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company. IBN has been compensated for advertising and digital media services for BOXABL Inc. This publication is for informational purposes only and is not, and should not be construed as, a research report, investment advice, or a recommendation to buy or sell any security. The information contained herein is believed to be reliable but no guarantee can be made as to its accuracy or completeness. Neither IBN nor NNW is registered as an investment adviser or broker-dealer. Readers should review BOXABL Inc.’s filings with the U.S. Securities and Exchange Commission and consult with a licensed financial advisor before making any investment decision. Please see the full terms of use and disclaimers applicable to all content provided by IBN, wherever published or re-published, at https://IBN.fm/Disclaimer.

Disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertisements.

• SuperQ is making quantum computing more accessible through its integrated Super(TM) platform for enterprises, research and government users.
• The company is connecting quantum computing, high-performance computing and AI to address complex optimization, simulation and cybersecurity challenges.
• SuperQ is building toward an integrated quantum-computing ecosystem spanning Super(TM), Super OS(TM) and Super Nova(TM), supported by expanding commercial and technology partnerships.

Quantum computing is moving from research environments toward practical applications, but bringing the technology into mainstream computing infrastructure presents a challenge of its own. Organizations already depend on CPUs, GPUs, high-performance computing and increasingly artificial intelligence, while quantum processors introduce entirely new architectures and methods of computation.

SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) is positioning itself at the intersection of these technologies, developing an integrated ecosystem designed to connect quantum resources with the classical computing infrastructure enterprises, researchers and governments already rely on.

At the center of that strategy is Super(TM), the company’s flagship hybrid computing platform. Super is designed to combine quantum annealing, gate-based quantum computing and high-performance computing, allowing users to work with CPUs, GPUs and quantum processing units through a unified environment.

The platform is designed to analyze problems, generate and deploy computational models, execute them across available computing resources and present resulting insights to users. Rather than treating quantum computing as an isolated technology, SuperQ is building an environment in which quantum and classical resources can be deployed together according to the requirements of a particular computational problem.

From Software Platform to Computing Infrastructure

Super represents the application layer of SuperQ’s broader architecture, but the company’s strategy extends beyond software.

In July 2026, SuperQ announced Super OS(TM), an operating system designed to orchestrate CPUs, GPUs and quantum processing units through a unified execution fabric. The company is developing Super OS as a control layer capable of connecting heterogeneous computing resources without requiring users to manage each system independently.

That development provides a bridge between SuperQ’s software platform and its hardware ambitions.

At the hardware level, SuperQ is developing Super Nova(TM), a modular hybrid quantum computer designed to run Super OS natively. The system is intended to combine quantum processing with classical computing resources, providing a potential path toward more integrated and flexible deployment of hybrid computing.

The development of Super Nova has also gained a more defined technical foundation. In September 2026, SuperQ announced that the quantum hardware layer is being developed at the University of Waterloo’s Digital Quantum Matter Lab under the supervision of Professor Matteo Mariantoni, a researcher specializing in superconducting quantum physics.

SuperQ is also recruiting additional quantum hardware scientists at the Waterloo lab to work across areas including quantum chip design, device fabrication, cryogenics and hardware-software orchestration.

Together, these efforts represent a progression from an application platform to an orchestration layer and ultimately to dedicated hybrid quantum infrastructure.

Expanding the Quantum Ecosystem

SuperQ is also working to broaden the range of quantum technologies available through its platform.

In March 2026, the company announced a memorandum of understanding with India’s Quanfluence, a photonic quantum technology company, focused on integrating Quanfluence’s quantum random number generator and quantum computing capabilities into Super and pursuing joint global commercialization. The agreement followed a joint demonstration at CES 2026.

The company is simultaneously pursuing commercial applications for its technology in areas where optimization and computational efficiency can have significant economic value, including financial services, enterprise risk, logistics and artificial intelligence.

In May 2026, SuperQ announced a commercial agreement with AI Financial Corporation focused on post-quantum security and compute tokenization, providing a commercial application for the company’s broader hybrid-computing strategy.

These developments illustrate the role SuperQ is seeking to play within the emerging quantum ecosystem: not simply developing a quantum processor but connecting different forms of advanced computing and making them accessible through a common environment.

Building Toward Quantum Utility

Developing that ecosystem requires both technology and resources. In June 2026, SuperQ closed an oversubscribed brokered LIFE financing that generated C$4 million in gross proceeds. The company said the financing would support ongoing technology and commercialization initiatives, including its quantum hardware and operating-system efforts.

The broader architecture can therefore be viewed across three connected layers.

As SuperQ continues developing Super Nova at the University of Waterloo, expanding Super OS and adding new quantum capabilities and commercial relationships to its ecosystem, the company is working toward a model in which quantum and classical computing resources can be deployed together according to the requirements of a particular problem.

The broader objective is to make quantum computing less of an isolated technology and more of a practical component of the next generation of high-performance computing.

For more information, visit www.superq.co.

NOTE TO INVESTORS: The latest news and updates relating to QBTQF are available in the company’s newsroom at ibn.fm/QBTQF

Disseminated on behalf of Redwood AI Corp. and may include paid advertising.

• The company has been named a co-applicant in a competitive Terry Fox Research Institute grant awarded to advance Onco-Innovations’ SynoGraph(TM) oncology platform.
• The project will investigate whether causal AI can improve predictions of first-in-human clinical outcomes using preclinical and real-world clinico-genomic data.
• Redwood AI will contribute proprietary data integration and physicochemical modelling methods to expand SynoGraph’s predictive capabilities.
• The grant supports a project with an estimated budget of $3.5 million and reimburses eligible costs up to 25% of that amount.
• Academic partners will provide clinico-genomic and imaging data for research using federated learning, which is intended to support analysis while protecting data privacy.

Redwood AI (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N, WKN: A422EZ), developer of an AI-powered platform for real-world applications across multiple critical industries, is joining a Canadian research collaboration backed by the Terry Fox Research Institute, contributing its data integration and chemical modelling expertise to the development of SynoGraph(TM), an artificial intelligence platform being developed by Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) for oncology research.

A September 22 announcement names Onco as lead applicant, with Redwood AI, the Michael Smith Genome Sciences Centre and the Centre de recherche du CHU de Québec-Université Laval as co-applicants. The project, titled “Causal AI to Predict First-in-Human Clinical Outcomes from Preclinical and Real-World Clinico-Genomic Data,” will explore how AI methods can help researchers estimate clinical outcomes before therapies enter human trials (https://ibn.fm/pdO4u).

The Digital Health Innovation Fund award is structured as a reimbursement-based grant covering up to 25% of an estimated $3.5 million project budget. Each co-applicant is an individual recipient under the grant, with participation governed by contribution agreements. The announcement does not specify the amount allocated to Redwood AI or the timing of reimbursements.

The project adds a life-sciences application to Redwood AI, which also develops AI and cybersecurity technologies for defense and public safety. The company’s stated chemistry platform is designed to support molecule design, chemical synthesis planning and analysis of complex chemical data.

Under the collaboration, Redwood AI will provide proprietary methods for data integration, feature engineering and physicochemical property evaluation. These capabilities are intended to complement Onco’s work in causal AI and federated pipeline development.

Onco is developing SynoGraph through its subsidiary Inka Health, while Redwood AI is contributing tools focused on chemical and data modelling. The academic institutions will provide clinico-genomic and imaging data to support the research.

A key component is federated learning, an approach that allows participating institutions to train or evaluate models across distributed datasets without necessarily pooling sensitive patient-level information in one central repository. The project aims to combine this approach with causal AI, which seeks to distinguish relationships that may be predictive from those that may reflect underlying causes.

The intended application is to improve predictions of how investigational therapies may perform in people, using evidence gathered before clinical testing alongside real-world clinical and genomic information. Such predictions could inform decisions about which candidates warrant further study, although the grant announcement does not report validated accuracy measures or clinical outcomes from SynoGraph.

The research also reflects a broader challenge in drug development: preclinical findings do not always translate into successful human trials. AI systems that integrate different types of biological and clinical evidence are being investigated as tools to support research decisions, but their value depends on data quality and performance in settings beyond the data used to build them.

Redwood AI said its contribution could potentially expand SynoGraph’s predictive core by applying its experience in chemical modelling to complex, multimodal data. The company’s chief executive, Louis Dron, described the collaboration as an opportunity to combine its technology with Onco’s causal-AI expertise.

“Redwood AI will contribute proprietary data integration and physicochemical modelling methods that can potentially expand the predictive core of SynoGraph. By combining our technology and experience with chemical modelling with Onco’s expertise in causal AI, this project aims to demonstrate how Canadian AI companies can work together with complex multimodal data sources to advance therapeutic innovation,” said Dron.

Onco’s own development program includes ONC010, a preclinical candidate based on a PNKP inhibitor and a licensed nanoparticle delivery system. The company says it is designed to exploit synthetic lethality in biomarker-selected tumors and potentially sensitize them to DNA-damaging therapies. Onco has indicated that it expects clinical translation in mid-2027; that timeline is separate from the SynoGraph grant project.

The Terry Fox Research Institute, established in 2007, funds collaborative cancer research across Canada. Its Digital Health Innovation Fund operates within the broader Digital Health and Discovery Platform, a pan-Canadian initiative supported by a $49 million allocation through Innovation, Science and Economic Development Canada.

The award provides a concrete example of Redwood AI applying its technology in a collaborative research setting, with a defined contribution and a project supported by a national cancer research organization. It does not, by itself, establish that SynoGraph can reliably predict clinical outcomes or that Redwood AI will receive material commercial revenue from the work. The project’s progress will depend on execution across the consortium, access to usable datasets and evidence that the combined methods deliver reproducible predictive improvements. 

For more information, visit the company’s website at www.RedwoodAI.com.

NOTE TO INVESTORS: The latest news and updates relating to RDWCF are available in the company’s newsroom at https://ibn.fm/RDWCF

PAID ADVERTISEMENT. This article is a paid advertisement for BOXABL Inc. (Nasdaq: BXBL), distributed by NetworkNewsWire (“NNW”), a division of InvestorBrandNetwork (“IBN”). IBN has been compensated for advertising and digital media services related to BOXABL Inc. Readers should review the full disclaimer at the foot of this article before making any investment decision.

• BOXABL, transforming the housing market with its advanced modular building systems, has appointed Larry King, CPA, as Chief Financial Officer and Heather Clayton as Chief Accounting Officer.
• The appointments add extensive public-company reporting, accounting, operational and multi-entity experience to BOXABL’s management team.
• The company’s Casita platform uses folding modular construction, significantly simplifying transportation and accelerating installation, as BOXABL moves beyond individual units into larger developments.
• BOXABL recently highlighted projects ranging from disaster-relief housing and campground installations to residential and hospitality developments.

BOXABL (NASDAQ: BXBL), a technology company reinventing housing with its modular building systems, transforming the housing market, is adding senior financial executives to its leadership team as the factory-built housing company moves into its first full period as a publicly traded business.

The company announced on September 15 that Larry King, CPA, had joined as Chief Financial Officer and Heather Clayton as Chief Accounting Officer (https://ibn.fm/wQxep). The appointments come less than two months after BOXABL began trading on NASDAQ following the completion of its business combination with FG Merger II Corp. The additions are focused on financial reporting, accounting infrastructure and operational controls.

King brings more than 35 years of experience in finance, accounting and operations spanning gaming, manufacturing, hospitality and healthcare. His background includes SEC reporting, mergers and acquisitions, corporate accounting and operational restructuring.

Among his previous roles, King served as CFO of Chukchansi Gold Resort & Casino, where he was responsible for compliance with a $250 million bond indenture and prepared Form 10-K and 10-Q filings. He also served as treasurer and CFO of Riviera Holdings Corporation, a publicly traded company, and held senior finance positions at Tropicana Entertainment and Sahara Hotel & Casino.

His experience also includes work on the sale of Companion Animal Practices North America to Veterinary Centers of America, a transaction valued at $516 million on an enterprise basis. King led accounting integration involving 56 entities in connection with that transaction.

Clayton brings nearly a decade of experience building finance and accounting operations for expanding organizations. She spent six years with the Vegas Golden Knights, progressing from Controller to Vice President of Finance and Accounting and eventually CFO.

During that period, the organization expanded from two entities to 13 in just over two years, while Clayton assumed financial oversight across venues, partner foundations and acquisitions. She later served as CFO of ASTOUND Group, an experiential design and fabrication company.

The appointments address a practical requirement accompanying its transition from a privately financed housing technology company to a public issuer. The company says it has raised more than $230 million from more than 50,000 investors since its founding in 2017. It began trading on NASDAQ as BXBL on July 20, 2026.

“Larry and Heather each bring the kind of finance leadership we need as we build out our public company infrastructure,” said Paolo Tiramani, founder and CEO of BOXABL. “Larry’s deep SEC reporting experience and Heather’s track record scaling complex, multi-entity organizations will be valuable as we strengthen our foundation for the road ahead.”

The timing also comes as BOXABL’s commercial activity increasingly extends beyond individual home sales. On Sept. 9, the company detailed a portfolio of completed and developing projects across several U.S. markets (https://ibn.fm/2n1K2). The examples included a permanent installation of 12 park-model RV Casitas at American Campground in Las Vegas and a Casita supplied for wildfire-relief efforts in Pasadena, California.

In Oklahoma City, a BOXABL developer completed a 12-unit stacked Casita project for Catholic Charities. The same developer subsequently launched the Pasadera Casita Community near Stillwater, Oklahoma, a 12-unit short-term rental development positioned near Oklahoma State University.

BOXABL has also been working with Horizons Getaways on an eco-luxury resort network. The company said it had delivered 10 units to properties in Patrick, South Carolina, and Grapeland, Texas, with additional locations planned.

These projects illustrate the range of applications BOXABL is pursuing for its modular system, from individual units to hospitality and multi-unit developments.

The company’s foundational product remains the Casita, a basic modular unit, incorporating a kitchen, bathroom and utilities. BOXABL’s manufacturing system is designed so the building can be transported in a folded configuration before being expanded and installed at its destination.

BOXABL says its folding construction approach is specifically designed to reduce transportation complexity compared with conventional modular structures. Its technical library includes specifications for studio, one-bedroom and two-bedroom Casita configurations.

The company is now developing stackable and connectable modules intended for larger residential configurations. BOXABL’s developer platform describes applications ranging from single-family housing and townhomes to multifamily projects and other larger structures.

Commercial commitments are beginning to reflect that broader strategy. On Sept. 1, BOXABL announced a multiyear purchase agreement with LC Vegas Acquisitions, LLC covering up to 1,500 homes over three years. The agreement contemplates approximately 500 homes annually, although purchases remain subject to project schedules, site readiness, regulatory approvals and other conditions.

The company makes clear that the agreement does not require all 1,500 homes to be purchased. BOXABL stated that contemplated purchases may be modified, delayed, reduced or terminated under the agreement and that there is no assurance all units will ultimately be purchased, manufactured or delivered.

BOXABL has been expanding its product range alongside that effort. In addition to the Casita, the company has announced the Baby Box, a smaller unit designed around RV-code requirements that remains in the prototype phase, with a production start date not yet determined, while continuing development of larger configurations that can be connected or stacked.

For more information, visit the company’s website at www.Boxabl.com.

NOTE TO INVESTORS: The latest news and updates relating to BXBL are available in the company’s newsroom at https://ibn.fm/BXBL

Cautionary Note Regarding the Business Combination and Capital Structure. BOXABL Inc. became a publicly traded company through a business combination with FG Merger II Corp., a special purpose acquisition company, completed in July 2026, with the shares beginning trading on the Nasdaq Stock Market under the symbol BXBL on July 20, 2026. Companies that become public through special purpose acquisition transactions may be subject to risks including share price volatility, dilution, limited operating history as a public company, and redemption-related capital reductions. In July 2026 the Company filed a universal mixed shelf registration statement that would permit it to offer up to $500,000,000 of securities over time; any such issuance would be dilutive to existing holders. References to capital raised since inception and to the number of investors are as disclosed by the Company. Readers should review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov, including its periodic reports, in full.

Cautionary Note Regarding Forward-Looking Statements. This publication contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including projections of market opportunity and market share, estimates of customer adoption, projections of development and commercialization costs and timelines, expectations regarding the Company’s ability to execute its business model, the deployment of the Casita, the development and potential production of the Baby Box and of stackable and connectable modules, the pursuit of additional state regulatory approvals, expectations concerning relationships with customers, developers, strategic partners, suppliers, governments and regulatory bodies, the Company’s public-company reporting and finance infrastructure, and the potential for future projects, including purchases contemplated under developer agreements that are subject to conditions and that may be modified, delayed, reduced or terminated. Such statements are generally identified by words such as “plan”, “project”, “will”, “estimate”, “intend”, “expect”, “believe”, “target”, “continue”, “could”, “may”, “might”, “possible”, “potential” or “predict”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause actual circumstances, events, or results to differ materially, including manufacturing, supply chain, permitting, regulatory, financing, dilution, listing, competitive and market risks, and other risks identified in the Company’s filings with the Securities and Exchange Commission. Do not place undue reliance on such statements. The forward-looking statements in this publication are made as of the date above and IBN undertakes no obligation to update them.

Full Disclaimer. NetworkNewsWire (“NNW”) is a division of InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company. IBN has been compensated for advertising and digital media services for BOXABL Inc. This publication is for informational purposes only and is not, and should not be construed as, a research report, investment advice, or a recommendation to buy or sell any security. The information contained herein is believed to be reliable but no guarantee can be made as to its accuracy or completeness. Neither IBN nor NNW is registered as an investment adviser or broker-dealer. Readers should review BOXABL Inc.’s filings with the U.S. Securities and Exchange Commission and consult with a licensed financial advisor before making any investment decision. Please see the full terms of use and disclaimers applicable to all content provided by IBN, wherever published or re-published, at https://IBN.fm/Disclaimer.

• American Fusion has reported positive new experimental results from its Texatron(TM) fusion-energy development program, involving high-voltage pulsed magnetic-field experiments.
• The latest configuration produced hotter and denser toroidal plasmas than those observed during earlier high-current experiments.
• American Fusion also reported that the plasma structures remained stable against significant magnetohydrodynamic (“MHD”) instabilities during the experimental pulses.
• The results are intended to support the Texatron(TM) concept of rapidly compressing plasma to increase temperature and density in a pulsed fusion architecture.
• Further testing is expected to focus on quantitative measurements, repeatability and progressively more demanding operating conditions relevant to deuterium-helium-3 fusion.

American Fusion(TM) (OTCBQ: AMFN), a developer of next-generation fusion energy technologies, has reported a new set of experimental results from its Texatron(TM) fusion-energy program, saying pulsed magnetic-field experiments generated hotter and denser toroidal plasmas while maintaining stability during the compression events (https://ibn.fm/zmIV2).

The company said its technical team used high-voltage capacitor banks to generate short-duration, high-intensity magnetic fields designed to rapidly compress, or implode, a toroidal plasma. According to American Fusion(TM), the latest configuration produced plasma conditions that were hotter and denser than those observed during earlier high-current experiments.

The company also reported that the toroidal plasma structures remained stable against significant magnetohydrodynamic (“MHD”) instabilities during the experimental pulse. That observation is relevant to the Texatron(TM) development program because plasma stability is a fundamental consideration in fusion research. A plasma can become distorted or disrupted by instabilities, potentially interfering with the ability to achieve and maintain the conditions required for fusion.

American Fusion(TM) is pursuing a pulsed rather than continuously sustained approach. In the company’s architecture, electrical energy stored in capacitor banks is discharged rapidly to create a strong transient magnetic field. That field compresses the plasma, with the company seeking to use the resulting compression and shock processes to increase temperature and density.

The latest tests therefore address two physical behaviors that American Fusion(TM) says are central to its development strategy: increasing plasma temperature and density through rapid compression while preserving the structure of the toroidal plasma.

The company said Fabrice David, scientific researcher, inventor, and strategic advisor who serves as independent director or the company, was present during the latest testing sessions and independently observed the experiments and resulting data. American Fusion(TM) specifically noted, however, that David’s observations should not be interpreted as third-party laboratory certification, peer review or independent validation of commercial fusion performance. 

The next phase of development is expected to place greater emphasis on quantitative characterization and repeatability. American Fusion(TM) said future experiments will examine parameters including plasma temperature, density, magnetic-field strength, compression behavior, confinement time and stability. The company also plans to continue work toward operating conditions relevant to its proposed deuterium-helium-3, or D–³He, fusion approach.

That fuel cycle is central to the company’s longer-term architecture. The principal D–³He reaction produces energetic charged particles, and American Fusion(TM) is developing a concept intended to convert energy from the expanding plasma directly into electricity through electromagnetic induction.

The proposed sequence involves an electrical pulse producing magnetic compression, followed by shock heating and fusion. After the pulse, the company envisions the energized plasma expanding against the surrounding magnetic field, creating changing magnetic flux that could induce electrical current in surrounding conductors.

This direct-conversion approach differs from the conventional thermal pathway used in most electricity generation, where heat is converted into mechanical energy and then electricity. For American Fusion(TM), demonstrating the proposed magnetic-armature concept is therefore a separate technical objective from demonstrating the plasma conditions themselves. The direct-conversion system has not yet been demonstrated as a commercial power-generation technology.

The new testing also comes as American Fusion(TM) expands its engineering team. Travis Yakimishyn has assumed the role of Senior Electrical Engineer, with responsibilities focused on the design, development and testing of electrical systems supporting Texatron(TM).

The company’s broader strategy is to develop the Texatron(TM) as a modular fusion-energy platform for potential industrial, commercial, defense and grid-constrained applications. Its stated longer-term objective is infrastructure-grade power generation, but the technology remains in the experimental development stage.

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to AMFN are available in the company’s newsroom at https://ibn.fm/AMFN

• One of the challenges in cartilage repair is that some procedures can provide meaningful short-term pain relief without restoring durable, functional cartilage capable of withstanding the demands of an active joint.
• Regentis Biomaterials is taking a regenerative approach with GelrinC, a cell-free, off-the-shelf hydrogel designed to temporarily fill cartilage defects while guiding the healthy surrounding tissue to regenerate new, natural and highest hyalin quality cartilage.
• Recent long-term MRI and peer-reviewed clinical data have provided additional evidence supporting the quality and durability of knee cartilage regenerated with GelrinC, as the company advances its U.S. pivotal trial and commercialization efforts in Europe.

Cartilage repair is intended to do more than simply reduce pain. Ideally, proper treatment should also restore the cartilage tissue responsible for the smooth movement and durability of a healthy joint.

That can be difficult to achieve.

One challenge is that some commonly used cartilage-repair procedures encourage the formation of fibrocartilage rather than native hyaline cartilage. Fibrocartilage can fill structural defects and provide pain relief, but it does not have the same properties as hyaline cartilage, the smooth, resilient tissue that normally covers the surfaces of joints.

That distinction becomes particularly important over time. A treatment that provides short-term pain relief does not necessarily address the underlying loss of durable cartilage, potentially leaving younger and active patients facing additional procedures as joint damage progresses.

Regentis Biomaterials Ltd. (NYSE American: RGNT) is developing a regenerative approach designed to address that challenge with GelrinC, its lead product for the treatment of painful focal articular knee cartilage injuries.

The company’s lead product, GelrinC, is a cell-free, off-the-shelf hydrogel that is introduced directly into a cartilage lesion. Rather than permanently replacing the damaged tissue, the implant is designed to temporarily fill the defect while creating an environment that supports surrounding cells to regenerate new cartilage as GelrinC itself is resorbed.

GelrinC is introduced into the cartilage lesion using a syringe. Once the defect is filled, a UV beam cures the material into a soft, rubbery implant that temporarily occupies the damaged area.

From there, the process shifts from implantation to regeneration.

As the GelrinC implant gradually resorbs, the surrounding cartilage lesion rim forms aggregates and new cartilage begins to advance from the rims toward the center filling the space left by the retreating GelrinC implant. In time, the implant is completely resorbed, and new healthy cartilage covers the treated lesion.

According to the company’s clinical data, the regenerated cartilage is like healthy, native hyaline cartilage of the patient’s own. More recent imaging data provide additional insight into how that regenerated tissue develops over time.

In a clinical study followed to 24 months, GelrinC-treated patients demonstrated layered cartilage architecture comparable to native hyaline cartilage, according to long-term MRI data reported by Regentis. The company said the analysis used validated MRI methodologies accepted by U.S. and European regulators and showed progressive maturation and organization of the regenerated cartilage over time.

The findings complement previously reported clinical results from the company’s Phase II, which treated 56 patients across multiple sites in Israel and Northern Europe and followed patients for up to five years.

According to Regentis, patients treated with GelrinC demonstrated greater improvement in pain measurements compared with traditional microfracture. No serious adverse events were observed in the completed study.

GelrinC was also reviewed in peer-reviewed articles of the Cartilage journal using quantitative MOCART assessment of the complete Phase II follow-up dataset. The analysis demonstrated durable morphological cartilage repair through the standard two years follow-up and provided additional support for the quality and durability of the regenerated tissue.

Together, these findings are particularly relevant to the central challenge facing cartilage repair: not simply filling a defect but producing tissue that can mature and potentially provide lasting joint function.

That objective is now being evaluated in a larger U.S. clinical program.

Regentis has treated 43 of the 80 planned patients in its U.S. pivotal Phase III trial and expects to complete enrollment around the end of 2026. The company has also expanded its U.S. clinical site network while adding sites across Europe as it builds a broader clinical network.

At the same time, Regentis is preparing for potential commercialization in Europe, where GelrinC already has CE Mark approval. The company is engaging physicians and clinical centers and expanding surgeon training through its European Centers of Excellence.

Manufacturing is another part of that commercialization effort.

Regentis recently developed and filed patents covering a new solvent-free manufacturing process that the company says increases GelrinC production yield by 400%. In July 2026, the company received regulatory approval for the new manufacturing process from the European Notified Body, supporting manufacturing scale-up for anticipated European commercial requirements and future market expansion.

The combination of clinical development, manufacturing improvements and commercialization preparation gives GelrinC a broader development story than simply another approach to treating knee pain.

The underlying question is whether damaged cartilage can be repaired in a way that provides more than temporary relief, by encouraging the regeneration of tissue that more closely resembles the structure and characteristics of native cartilage. Regentis is now advancing GelrinC toward that goal through its U.S. pivotal trial while simultaneously preparing its European infrastructure for potential commercialization.

If successful, the approach could provide physicians with a cell-free, off-the-shelf product option designed to regenerate cartilage rather than simply manage the symptoms associated with its loss.

NOTE TO INVESTORS: The latest news and updates relating to RGNT are available in the company’s newsroom at ibn.fm/RGNT

This content was disseminated on behalf of (NYSE American: RGNT) as part of a paid marketing engagement with IBN.Ai

RGNT: IBN will receive $30,000 per quarter for a total of 180 days from RGNT for coverage via IBN

Please see full terms of use and disclaimers on the IBN website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

Disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertisements.

• Super(TM) combines classical optimization, GPU computing and quantum processing through a commercialized hybrid computing platform powered by proprietary AI agents.
• SuperQ recently deployed Super Edge(TM) and its Super(TM) platform in a live U.S. defense field exercise evaluating real-time decision support, dynamic route optimization and post-quantum communications.
• Commercial and government-backed initiatives are expanding SuperQ’s reach across financial services, U.S. defense, European public-sector markets and international quantum-computing ecosystems.

Access to advanced computing hardware is expanding rapidly. Quantum processors are increasingly accessible through cloud services, GPU capacity continues to grow across enterprise infrastructure, and classical optimization tools have become highly sophisticated. The challenge for many organizations is no longer whether these technologies exist, but how to use them together without building an internal team of specialists for every emerging computing architecture. 

SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) is focused on addressing that gap by connecting complex business and operational problems with the computing resources best suited to solving them.

Turning Advanced Computing into a Usable Platform

Generative AI and mathematical optimization serve different purposes. While a language model generates probable outputs based on learned patterns, optimization seeks solutions to defined objectives subject to specific constraints, whether that means optimizing fleet routes, balancing a portfolio or scheduling manufacturing operations.

Super(TM), SuperQ’s commercialized hybrid quantum and supercomputing platform, is designed to bring multiple computational approaches together. Its capabilities span problem modeling and decomposition, mathematical optimization, AI model optimization, GPU computing, gate-based quantum computing and quantum annealing, along with the interpretation and visualization of results.

The platform also incorporates Super Autopilots, proprietary AI agents designed to autonomously build and execute solutions to complex optimization and cybersecurity problems. Super can work across classical solvers, NVIDIA GPUs and quantum processing units, including systems from D-Wave and IonQ, with results delivered through Super Notebooks designed to translate complex computation into usable operating information.

That architecture gives SuperQ a technology platform capable of addressing optimization and decision-making challenges across areas including logistics, energy, healthcare, transportation and manufacturing.

The company is extending that ecosystem beyond optimization as well. SuperPQC(TM) is its post-quantum cybersecurity suite, designed to assess cryptographic vulnerabilities and support migration toward quantum-resistant security. In May 2026, SuperQ announced a commercial agreement with AI Financial Corporation covering deployment of SuperPQC across its technology stack and integration of Super hybrid computing into its digital asset infrastructure.

Meanwhile, Super Edge(TM) extends the company’s technology into tactical and distributed environments, while ChatQLM(TM) brings hybrid computing to consumers through a conversational interface designed to allow users to describe complex numerical problems in natural language.

Further along the development roadmap, Super OS(TM) is being designed as an orchestration layer that can unify CPUs, GPUs and quantum processing units within a common execution environment. Super Nova(TM), meanwhile, is an in-development modular hybrid quantum computer designed to run Super OS natively for data centers, enterprise and secure on-site deployments.

Putting the Technology in Front of the Buyer

For SuperQ, demonstrating the practical application of its technology is becoming increasingly important.

On August 21, 2026, the company deployed Super Edge and its Super platform at the Bush Combat Development Complex on Texas A&M University’s RELLIS Campus as part of a live operational exercise organized through the Canada Q-Branch Dual-Use Accelerator with support from Global Affairs Canada.

SuperQ was the only Canadian technology company deployed in the exercise, which was attended by U.S. military personnel, intelligence community representatives, defense contractors and investors.

During a simulated contested extraction, SuperQ’s architecture was evaluated under a formal Memorandum of Observation against several operational benchmarks. These included delivering a re-optimized course of action to tactical devices within 60 seconds of a threat change, maintaining route continuity across multiple sequential threat injections, transporting movement plans through satellite connections using post-quantum encryption and linking field devices with command headquarters.

Super Edge operated on devices carried by field personnel, collecting telemetry and returning position reports, while the centralized Super platform used that information to calculate routing and deployment options. The exercise provided a live environment in which SuperQ’s hybrid computing architecture could be evaluated against the types of dynamic decision-making challenges faced in tactical settings.

Building Commercial and Government Channels

The defense exercise followed SuperQ’s selection into the Canada and Q-Branch Dual-Use Accelerator, providing a channel for U.S. market entry, federal contracting and commercial execution.

The company is also pursuing opportunities beyond North America. SuperQ was selected for Deep Tech Canada’s trade mission to Barcelona in November 2026, where it plans to demonstrate Super, Super OS and Super Nova against mobility, decentralized energy and smart-city planning challenges for public-sector buyers.

At the same time, the company is building a broader international ecosystem through its Super Hub network. The initiative is designed to provide physical access, training and collaboration opportunities around advanced computing technologies, with hubs already established in Canada and the UAE and additional international expansion planned.

Together, these initiatives reflect a broader strategy: rather than positioning quantum computing as a technology that customers must master independently, SuperQ is building an ecosystem intended to make advanced computing more accessible, practical and deployable.

As quantum processors, GPUs and classical computing resources continue to evolve in parallel, the value may increasingly lie not simply in access to individual technologies, but in the ability to determine which tools should be used, how they can work together and how their outputs can be translated into actionable decisions.

That is the market SuperQ is pursuing – serving as the connecting layer between the problem, the hardware and the decision.

For more information, visit www.superq.co.

NOTE TO INVESTORS: The latest news and updates relating to QBTQF are available in the company’s newsroom at ibn.fm/QBTQF